MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2020)Next Year (2021)
No. of Analysts11111211
Avg. Estimate0.320.491.822.02
Low Estimate0.310.451.721.8
High Estimate0.380.541.872.2
Year Ago EPS0.430.381.671.82
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2020)Next Year (2021)
No. of Analysts11111211
Avg. Estimate202.24M223.2M873.85M912.58M
Low Estimate200.31M218.8M856.3M880.04M
High Estimate206.4M228.25M900M947M
Year Ago Sales202.37MN/A851.1M873.85M
Sales Growth (year/est)-0.10%N/A2.70%4.40%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.0.30.390.420.47
EPS Actual0.430.380.460.41
Difference0.13-0.010.04-0.06
Surprise %43.30%-2.60%9.50%-12.80%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2020)Next Year (2021)
Current Estimate0.320.491.822.02
7 Days Ago0.420.51.922.17
30 Days Ago0.420.491.862.07
60 Days Ago0.420.51.892.13
90 Days Ago0.390.461.882.08
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/A42N/A
Up Last 30 Days142N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days96107
Growth EstimatesMYGNIndustrySectorS&P 500
Current Qtr.-25.60%N/AN/A-0.00
Next Qtr.28.90%N/AN/A0.08
Current Year9.00%N/AN/A0.03
Next Year11.00%N/AN/A0.10
Next 5 Years (per annum)14.99%N/AN/A0.08
Past 5 Years (per annum)-3.63%N/AN/AN/A